HOME >> MEDICINE >> NEWS
Selective and nonselective beta-blockers equally effective in preventing sudden death

DALLAS - September 2, 1999 - A new study from UT Southwestern Medical Center at Dallas should encourage cardiologists to prescribe either selective or nonselective beta-blockers to patients with congestive heart failure. Researchers found both types of drugs equally effective in reducing the risk of sudden death.

In a study of 26 patients with congestive heart failure, researchers from UT Southwestern and Dallas Veterans Affairs Medical Center found no difference in the reduction of QTc dispersion -- a marker of risk for sudden death -- between those treated with selective beta-blockers and those treated with nonselective beta-blockers. Their findings were published in the August issue of The American Journal of Cardiology.

The scientists compared the electrocardiograms (ECG) of the patients before and after three months of therapy with either a selective beta-blocker, which inhibits the beta 1 receptor, or a nonselective beta-blocker, which inhibits both the beta 1 and the beta 2 receptors.

Congestive heart failure kills more than 43,000 people in the United States annually. A number of recent studies have shown that physicians underprescribe beta-blockers because of their side effects despite clinical-trial reports that congestive-heart-failure patients who take them are 43 percent less likely to die during the first two years following a first heart attack than those who do not take them. Side effects may include depression, worsening asthma, tiredness and sexual dysfunction, although many physicians note that the heart attack itself may produce these.

"This is significant because it gives us a better idea of how effective different beta-blockers are in treating congestive heart failure," said Dr. Eric Eichhorn, UT Southwestern professor of internal medicine and director of the cardiac catheterization laboratory at the VA Medical Center. "The findings give doctors more options in treating their patients and help us a
'"/>

Contact: Susan Steeves
susan.steeves@email.swmed.edu
214-648-3404
UT Southwestern Medical Center
31-Aug-1999


Page: 1 2

Related medicine news :

1. Selective coatings create biological sensors from carbon nanotubes
2. Selective inhibitor can target specific enzyme that promotes cancer
3. In heart failure, beta-blockers boost survival advantage for women
4. Wider use of beta-blockers after heart attacks could save thousands of lives at a reasonable cost, new study shows
5. Aspirins potential ability to prevent colon polyps may not apply equally to all
6. New guidelines conclude all aerosol therapy devices equally effective
7. Baby and coated aspirin equally effective in thinning of blood when taken in combination with Plavix
8. Beta-blocker or calcium antagonist-based therapies equally effective in treating hypertension
9. Smoking cessation success equally good with over-the-counter or prescription nicotine replacement
10. Strategy effective against drug resistant tuberculosis
11. Study shows patch therapy may be as effective as oral medications

Post Your Comments:
(Date:12/22/2014)... CA (PRWEB) December 22, 2014 ... now offering consultations for sleep apnea. Drowsy drivers are ... than drivers who are well-rested, and some experts believe ... the roads as intoxicated drivers. Unfortunately, millions of Americans ... the American Academy of Sleep Medicine, about 18 million ...
(Date:12/22/2014)... Luxury Linen purveyor Peacock Alley ... to provide logistics and support for one of Dallas’ ... a long history of giving back to the community in ... year's Toy Drive were Whataburger® and 99.5 The Wolf. , ... holidays. Providing gifts to children who would otherwise not receive ...
(Date:12/22/2014)... 21, 2014 A substantial percentage ... computed tomography (CT) to evaluate abnormal findings on ... cancer, according to a new study published online ... the findings show that radiologist recommendations for additional ... to patient care. , RAIs, which have grown ...
(Date:12/21/2014)... (PRWEB) December 22, 2014 In ... is segmented by power source, product, and application. ... electric-powered, battery-powered, and pneumatic instruments. By product, the ... and accessories segments. The handpieces market is further ... devices, suction coagulators, laparoscopic instruments, shavers, wire/pin drivers, ...
(Date:12/21/2014)... 2014 Khanna Vision Institute is pleased ... the Aspen Helicopters holiday event for underprivileged kids. The ... sleigh, flown by an aspen helicopter pilot. In the ... with sleigh was visible.(please see accompanying video). Helicopter pilots ... has helped many pilots with Pi in eye vision ...
Breaking Medicine News(10 mins):Health News:Pasadena Dentist, Dr. Marine Martirosyan, Now Offers Consultations for Sleep Apnea 2Health News:Peacock Alley and Community Partners of Dallas Fulfill an Estimated 12,000 Holiday Wishes for Deserving Children 2Health News:RSNA: Radiologist Recommendations for Chest CT Have High Clinical Yield 2Health News:RSNA: Radiologist Recommendations for Chest CT Have High Clinical Yield 3Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 3Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 4
(Date:12/22/2014)... /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII ... and commercializing innovative therapies addressing major unmet medical ... open letter to shareholders from President & CEO, ... Dear RXi Shareholders, In the ... posted on certain social media sites seem to ...
(Date:12/22/2014)... 2014 TWi Biotechnology, Inc., today announced ... AC-201, TWi Biotechnology,s lead drug candidate, from The ... for patent application numbered 201180018154.8.  This ... active metabolite for treatment of type II diabetes.  ... using AC-201 for type II diabetes, and provides ...
(Date:12/19/2014)... KENNEWICK, Wash. , Dec. 19, 2014 /PRNewswire/ ... late stage development company engaged primarily in the ... diagnostic and therapeutic applications, today announced that a ... Grant has been awarded for which AMIC is ... Washington State University (WSU) for the proposal titled ...
Breaking Medicine Technology:RXi Pharmaceuticals Issues Open Letter to Shareholders 2RXi Pharmaceuticals Issues Open Letter to Shareholders 3RXi Pharmaceuticals Issues Open Letter to Shareholders 4RXi Pharmaceuticals Issues Open Letter to Shareholders 5RXi Pharmaceuticals Issues Open Letter to Shareholders 6TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in China 2TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in China 3Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner 2Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner 3
Cached News: